THE EFFICACY AND SAFETY OF CARBOPLATIN AND WEEKLY PACLITAXEL COMBINATION THERAPY FOR PREVIOUSLY TREATED SMALL CELL LUNG CANCER PATIENTS WITH INTERSTITIAL LUNG DISEASE

Retrospective Efficacy and Safety Analysis of Erlotinib (E), Pemetrexed (P) and Docetaxel (D) in Previously Treated Non-Small-Cell Lung Cancer Patients (NSCLC) without EGFR Mutation

Annals of Oncology ◽

10.1016/s0923-7534(20)33800-x ◽

2012 ◽

Vol 23 ◽

pp. ix437 ◽

Cited By ~ 1

Author(s):

J. Takeshita ◽

N. Katakami ◽

A. Nishiyama ◽

H. Yoshioka ◽

M. Iwasaku ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cancer Patients ◽

Cell Lung Cancer ◽

Egfr Mutation ◽

Small Cell ◽

Efficacy And Safety ◽

Small Cell Lung ◽

Lung Cancer Patients ◽

A phase I study of S-1 and irinotecan combination therapy in previously treated advanced non-small cell lung cancer patients

Cancer Chemotherapy and Pharmacology ◽

10.1007/s00280-010-1539-y ◽

2010 ◽

Vol 67 (3) ◽

pp. 717-722 ◽

Cited By ~ 2

Author(s):

Satoshi Yoda ◽

Kenzo Soejima ◽

Hiroyuki Yasuda ◽

Katsuhiko Naoki ◽

Ichiro Kawada ◽

...

Keyword(s):

Lung Cancer ◽

Combination Therapy ◽

Phase I ◽

Small Cell Lung Cancer ◽

Cancer Patients ◽

Phase I Study ◽

Small Cell ◽

Small Cell Lung ◽

Lung Cancer Patients ◽

Immune checkpoint inhibitor efficacy and safety in elderly non-small cell lung cancer patients

Annals of Oncology ◽

10.1093/annonc/mdy292.095 ◽

2018 ◽

Vol 29 ◽

pp. viii533-viii534

Author(s):

T. Kubo ◽

H. Watanabe ◽

K. Ninomiya ◽

K. Kudo ◽

D. Minami ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cancer Patients ◽

Immune Checkpoint ◽

Immune Checkpoint Inhibitor ◽

Checkpoint Inhibitor ◽

Small Cell ◽

Efficacy And Safety ◽

Small Cell Lung ◽

Efficacy and Safety of Crizotinib among Chinese EML4-ALK-Positive, Advanced-Stage Non-Small Cell Lung Cancer Patients

PLoS ONE ◽

10.1371/journal.pone.0114008 ◽

2014 ◽

Vol 9 (12) ◽

pp. e114008 ◽

Cited By ~ 12

Author(s):

Yabing Cao ◽

Guangli Xiao ◽

Xibin Qiu ◽

Sheng Ye ◽

Tongyu Lin

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cancer Patients ◽

Cell Lung Cancer ◽

Small Cell ◽

Advanced Stage ◽

Efficacy And Safety ◽

Small Cell Lung ◽

Lung Cancer Patients ◽

Alk Positive

Efficacy and safety of S-1 maintenance therapy in advanced non-small-cell lung cancer patients

World Journal of Clinical Cases ◽

10.12998/wjcc.v8.i21.5172 ◽

2020 ◽

Vol 8 (21) ◽

pp. 5172-5179

Author(s):

Xiao-Wei Cheng ◽

Wen-Hua Leng ◽

Chun-Ling Mu

Keyword(s):

Lung Cancer ◽

Maintenance Therapy ◽

Small Cell Lung Cancer ◽

Cancer Patients ◽

Cell Lung Cancer ◽

Small Cell ◽

Efficacy And Safety ◽

Small Cell Lung ◽

Differential expression of circulating biomarkers of tumor phenotype and outcomes in previously treated non-small cell lung cancer patients receiving erlotinib vs. cytotoxic chemotherapy

Oncotarget ◽

10.18632/oncotarget.17510 ◽

2017 ◽

Vol 8 (35) ◽

pp. 58108-58121 ◽

Cited By ~ 6

Author(s):

Mary Jo Fidler ◽

Casey Frankenberger ◽

Richard Seto ◽

Gabriela C. Lobato ◽

Cristina L. Fhied ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cancer Patients ◽

Cytotoxic Chemotherapy ◽

Small Cell ◽

Circulating Biomarkers ◽

Small Cell Lung ◽

Lung Cancer Patients ◽

Tumor Phenotype ◽

MA02.03 Impact of Coexisting Interstitial Lung Disease on Resected Non-Small Cell Lung Cancer Patients

Journal of Thoracic Oncology ◽

10.1016/j.jtho.2019.08.504 ◽

2019 ◽

Vol 14 (10) ◽

pp. S253

Author(s):

J.G. Lee ◽

S.Y. Park ◽

C.Y. Lee ◽

K.S. Narm ◽

S.H. Song

Keyword(s):

Lung Cancer ◽

Interstitial Lung Disease ◽

Small Cell Lung Cancer ◽

Lung Disease ◽

Cancer Patients ◽

Cell Lung Cancer ◽

Small Cell ◽

Small Cell Lung ◽

Improved efficacy of ramucirumab plus docetaxel after nivolumab failure in previously treated non‐small cell lung cancer patients

Thoracic Cancer ◽

10.1111/1759-7714.12998 ◽

2019 ◽

Vol 10 (4) ◽

pp. 775-781 ◽

Cited By ~ 18

Author(s):

Ayako Shiono ◽

Kyoichi Kaira ◽

Atsuto Mouri ◽

Ou Yamaguchi ◽

Kosuke Hashimoto ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cancer Patients ◽

Cell Lung Cancer ◽

Small Cell ◽

Small Cell Lung ◽

Lung Cancer Patients ◽

A multicenter single-arm phase II study of nab-paclitaxel/carboplatin for non-small cell lung cancer patients with interstitial lung disease

Annals of Oncology ◽

10.1093/annonc/mdy292.060 ◽

2018 ◽

Vol 29 ◽

pp. viii519-viii520 ◽

Cited By ~ 2

Author(s):

Y. Usui ◽

H. Kenmotsu ◽

K. Mori ◽

A. Ono ◽

K. Yoh ◽

...

Keyword(s):

Lung Cancer ◽

Interstitial Lung Disease ◽

Small Cell Lung Cancer ◽

Lung Disease ◽

Cancer Patients ◽

Phase Ii ◽

Phase Ii Study ◽

Small Cell ◽

Small Cell Lung ◽

Pemetrexed plus cisplatin/carboplatin in previously treated locally advanced or metastatic non-small cell lung cancer patients

Journal of Experimental & Clinical Cancer Research ◽

10.1186/1756-9966-29-38 ◽

2010 ◽

Vol 29 (1) ◽

pp. 38 ◽

Cited By ~ 11

Author(s):

Guan-Zhong Zhang ◽

Shun-Chang Jiao ◽

Zhao-Ting Meng

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cancer Patients ◽

Cell Lung Cancer ◽

Locally Advanced ◽

Small Cell ◽

Small Cell Lung ◽

Lung Cancer Patients ◽